Driving overall development of Xinjiang's pharmaceutical industry
Li Ke'ao, a member of the Xinjiang Committee of the Chinese People's Political Consultative Conference (CPPCC) and vice-general manager of New CICON, a pharmaceutical company based in the Xinjiang Uygur autonomous region, shares insights into the thriving development and global outlook of the region's pharmaceutical industry. The sector continues to experience rapid growth, expanding its markets along the Belt and Road Initiative, and into Southeast Asia. The establishment of the Xinjiang Traditional Chinese Medicine Trading Platform and a port for imported medicinal materials is laying a solid foundation for the sector's internationalization.
He hopes to bring more high-quality Xinjiang pharmaceutical products to the world, raising the global profile of the region's ethnic medicines.
- Buddhist body urges followers not to release lifeless items into the natural environment
- Report: Average age of China's workforce nearing 40
- Renowned actress He Qing passes away at age 61
- China steps up cultural heritage protection to keep its past alive for the future
- Xi Focus: Navigating headwinds and charting new blueprint
- Poyang Lake water levels fall below extreme low threshold
